Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02462200 · ClinicalTrials.gov registry record · Phase 2
Shave Margins in Breast Conservation Therapy
A Phase 2 study, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- Phase 2
- Development phase
- 81
- Enrollment target
NCT02462200: Clinical Trial Phase 2 study, sponsored by Washington University School of Medicine.
NCT02462200 is a Phase 2 study that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 81 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (39% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02462200, a Phase 2 study, was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 81 participants
- Enrollment target
Study Summary
The investigators propose a randomized controlled superiority trial of standard breast-conserving surgery (BCS) versus BCS with cavity shave margins (CSM). The main objectives of this trial will be to evaluate prospectively the impact of routine standardized CSM on margin status following primary surgery for early stage breast cancer (Stage 0 - II), on post-operative patient satisfaction and cosmetic outcomes, and on general intraoperative time and operative costs. A parallel group format will be implemented to compare this modified surgical therapy - BCS with CSM - with BCS alone, which is the current standard of care.
Interventions
- PROCEDURE Breast-conserving surgery (BCS)
- PROCEDURE Cavity shave margins (CSM)
- BEHAVIORAL BREAST-Q Questionnaire
- DEVICE 3-D breast imaging
- OTHER Indocyanine green
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2016-06-13 |
| Est. Completion | 2019-11-27 |
| Phase | Phase 2 |
Why NCT02462200 stopped before completion
NCT02462200 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 81 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (39% lower).
The record links to 0 conditions, and to 5 interventions - of which Breast-conserving surgery (BCS) is the first listed.
NCT02462200 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02462200 about?
NCT02462200 is a clinical study titled "Shave Margins in Breast Conservation Therapy". The investigators propose a randomized controlled superiority trial of standard breast-conserving surgery (BCS) versus BCS with cavity shave margins (CSM). The main objectives of this trial will be to evaluate prospectively the impact of routine standardized CSM on margin status following primary su...
What is the current status of trial NCT02462200?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 81 participants. The study started on 2016-06-13. Estimated completion is 2019-11-27.
What interventions are being tested in trial NCT02462200?
The interventions under investigation include: Breast-conserving surgery (BCS) (PROCEDURE), Cavity shave margins (CSM) (PROCEDURE), BREAST-Q Questionnaire (BEHAVIORAL), 3-D breast imaging (DEVICE), Indocyanine green (OTHER).
Who is sponsoring clinical trial NCT02462200?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02462200's enrollment target sits among peer trials
81 834th of 2000 higher than 1,159 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04966481 · 81 participants · Phase 3
Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor
- NCT05109429 · 81 participants · NA
Developing a Clinical Outcome Assessment for Opioid Craving
- NCT05112601 · 81 participants · Phase 2
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- NCT05305911 · 81 participants · Phase 2
Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI